EU RESEARCHERS CREATE NEW ALZHEIMERS CURE
January 1st, 2007
BY KEITH NUTHALLALZHEIMER'S Disease is being targeted by a European Union (EU) research project wanting to stimulate immune systems into attacking the condition's 42 amino acid-peptides that kill brain cells. The Mimovax project differs from previous Alzheimer's vaccine prototypes by prompting immune systems to attack only these specific peptides, rather than risking attacks on healthy beta amyloid proteins whose degeneration actually creates the disease's dangerous peptides.Project coordinator from Austrian company Affiris Dr Frank Mattner, said this was the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.